Trial Profile
A Randomized, Double-Blind, Placebo and Active-Controlled, Crossover Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Oct 2019
Price :
$35
*
At a glance
- Drugs Promethazine/hydrocodone/paracetamol (Primary)
- Indications Acute pain; Nausea and vomiting
- Focus Pharmacokinetics
- Sponsors Charleston Laboratories
- 22 Mar 2016 New trial record